Recuro Health
PrivateLast Round
Series B
Apr 11, 2023
Est. Valuation
$200M
Total Funding Raised
$69M
Company Overview
Recuro Health operates in Healthcare & Life Sciences and is based in Coppell, Texas. Its latest recorded funding round was a Series B round in April 2023.
Recuro Health is a digital health company that provides a virtual-first care delivery platform offering primary care, behavioral health, and urgent care services to employers, providers, and managed care organizations.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Mental Health, Patient Engagement
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Recuro Health Comparables
Compare Recuro Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| First Stop Health | 77% | |
| Amwell | 76% | |
| Quantum Health | 75% |
For institutional investors. Book with your work email.
Recuro Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 11, 2023 | ||||
| Convertible Debt | Mar 31, 2022 | ||||
| Series A Extension | Dec 7, 2021 | ||||
| Series A | Aug 25, 2021 | ||||
| Seed | Mar 30, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Recuro Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 1843 Capital | Series A, Seed |
| Oklahoma Life Science Fund | Seed, Series A |
| Flippen Group | Series B |
| GPG Ventures | Series B |
| DeepWork Capital | Series A Extension |
| ARCH Venture Partners | Series B, Convertible Debt, Series A |
| XB Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 20, 2025
Named one of the Top 25 Digital Health Companies of 2025.
- Sep 10, 2025
Michael Brombach promoted to EVP and Chief Operating Officer.
For institutional investors. Book with your work email.
Recuro Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Recuro Health's valuation, stock price, and market status.
Is Recuro Health a public or private company?
Recuro Health is a private company.
What is the current stock price of Recuro Health?
Recuro Health is a private company, so its shares have no public market price. Caplight tracks Recuro Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Recuro Health worth (valuation)?
Recuro Health's valuation is estimated at $200.0M based on funding round data.
Can I buy Recuro Health stock?
Recuro Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Recuro Health's last funding round?
Recuro Health's most recent funding round was Series B on April 11, 2023.
Who are the main investors in Recuro Health?
Key investors in Recuro Health include Oklahoma Life Science Fund, ARCH Venture Partners, Cortado Ventures.
Will Recuro Health IPO soon?
No public IPO plans have been announced for Recuro Health.
How can I track Recuro Health secondary market activity?
Caplight tracks bids, offers, and trades in Recuro Health's shares on secondary markets.